$668 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 28 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 72.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $145,126,000 | -21.2% | 2,123,271 | -1.2% | 21.73% | -5.8% |
| QDEL | Sell | QUIDEL CORP | $139,483,000 | -55.9% | 1,090,309 | -38.0% | 20.89% | -47.3% |
| AWH | ASPIRA WOMENS HEALTH INC | $58,368,000 | +0.6% | 8,647,094 | 0.0% | 8.74% | +20.2% | |
| OPK | Sell | OPKO HEALTH INC | $55,003,000 | +5.7% | 12,821,273 | -2.7% | 8.24% | +26.4% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $48,182,000 | +7.9% | 1,446,459 | -16.0% | 7.22% | +28.9% |
| Buy | DERMTECH INC | $36,243,000 | +148.3% | 713,577 | +58.6% | 5.43% | +196.8% | |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $31,417,000 | +8.9% | 3,776,121 | -0.8% | 4.70% | +30.2% |
| AGEN | Sell | AGENUS INC | $25,496,000 | -32.4% | 9,373,582 | -20.9% | 3.82% | -19.2% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $24,079,000 | +8.4% | 2,367,670 | -20.6% | 3.61% | +29.6% |
| VIR | New | VIR BIOTECHNOLOGY INC | $23,088,000 | – | 450,331 | +100.0% | 3.46% | – |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $12,947,000 | +156.4% | 2,084,839 | +101.9% | 1.94% | +206.3% |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $11,511,000 | +84.0% | 380,642 | +201.3% | 1.72% | +119.9% |
| CAPR | New | CAPRICOR THERAPEUTICS INC | $9,357,000 | – | 1,999,464 | +100.0% | 1.40% | – |
| CDAK | New | CODIAK BIOSCIENCES INC | $8,224,000 | – | 545,360 | +100.0% | 1.23% | – |
| ATRS | ANTARES PHARMA INC | $7,809,000 | +3.0% | 1,900,000 | 0.0% | 1.17% | +23.1% | |
| SEM | New | SELECT MED HLDGS CORP | $7,673,000 | – | 225,000 | +100.0% | 1.15% | – |
| CFRX | Buy | CONTRAFECT CORP | $7,452,000 | +780.9% | 1,552,423 | +826.3% | 1.12% | +952.8% |
| BDSX | BIODESIX INC | $4,783,000 | +14.0% | 235,511 | 0.0% | 0.72% | +36.1% | |
| MOTS | Sell | MOTUS GI HLDGS INC | $4,535,000 | +25.7% | 3,747,551 | -1.6% | 0.68% | +50.2% |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $2,686,000 | -62.1% | 2,132,000 | -41.9% | 0.40% | -54.7% |
| FORA | New | FORIAN INC | $1,571,000 | – | 155,440 | +100.0% | 0.24% | – |
| BIIB | Sell | BIOGEN INC | $675,000 | -25.2% | 2,412 | -34.6% | 0.10% | -10.6% |
| SEM | New | SELECT MED HLDGS CORPput | $585,000 | – | 100,000 | +100.0% | 0.09% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF INput | $505,000 | – | 100,000 | +100.0% | 0.08% | – |
| QDEL | New | QUIDEL CORPput | $363,000 | – | 50,000 | +100.0% | 0.05% | – |
| New | DERMTECH INCput | $356,000 | – | 46,900 | +100.0% | 0.05% | – | |
| VIR | New | VIR BIOTECHNOLOGY INCput | $221,000 | – | 19,000 | +100.0% | 0.03% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lput | $17,000 | – | 33,600 | +100.0% | 0.00% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INCcall | $0 | – | -200,400 | -100.0% | -0.02% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -100,000 | -100.0% | -0.05% | – |
| BIOL | Exit | BIOLASE INC | $0 | – | -1,739,100 | -100.0% | -0.09% | – |
| QDEL | Exit | QUIDEL CORPcall | $0 | – | -119,700 | -100.0% | -0.14% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -100,000 | -100.0% | -0.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.